TrialJAMA dermatology2024

Noninferiority of 16-Week vs 8-Week Guselkumab Dosing in Super Responders for Maintaining Control of Psoriasis: The GUIDE Randomized Clinical Trial.

Kilian Eyerich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.